Should you buy BLRX stock?

Last updated:

Based on market data through , StockInvest.us rates BioLineRx Ltd. (BLRX) as a Sell Candidate with a technical score of -1.72 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Up 0.07%
  • 3-month trend forecast Down 11.37%
  • Sell Candidate -1.72
AI Analysis AI Analysis of BLRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BLRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

BioLineRx Ltd. stock price ended at $2.71 on Monday, after gaining 0.0738%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 07, 2026 Gain 0.07%

The BioLineRx Ltd. stock price gained 0.0738% on the last trading day (Monday, 10th Aug 2026), rising from $2.71 to $2.71. During the last trading day the stock fluctuated 3.38% from a day low at $2.66 to a day high of $2.75. The price has fallen in 6 of the last 10 days and is down by -3.73% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 9 thousand shares were bought and sold for approximately $23.88 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.62 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -11.37% during the next 3 months and, with a 90% probability hold a price between $2.33 and $3.04 at the end of this 3-month period.

BLRX Signals & Forecast

There are mixed signals in the stock today. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.74 and $2.96. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Monday, August 03, 2026, and so far it has risen 1.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioLineRx Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioLineRx Ltd. stock

BioLineRx Ltd. finds support from accumulated volume at $2.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0900 between high and low, or 3.38%. For the last week, the stock has had daily average volatility of 5.61%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLRX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect BioLineRx Ltd. to open at $2.71, and during the day (based on 14 day Average True Range), to move between $2.62 and $2.80, which gives a possible trading interval of +/-$0.178 (+/-6.80%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 6.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.71 (0.07%) than the resistance at $3.01 (10.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

BioLineRx Ltd. will release earnings BMO on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.150. We will update the financials statements for BioLineRx Ltd., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.23% in the first trading day after earnings release.

Is BioLineRx Ltd. stock A Buy?

BioLineRx Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.720 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $2.71 ( 0.172%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BLRX Performance

Trading levels for BLRX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.80 3.15%
R2 2.76 1.88%
R1 2.74 1.10%
Price 2.71
S1 2.67 -1.44%
S2 2.65 -2.22%
S3 2.62 -3.49%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.37 24.26%
R2 3.26 20.21%
R1 3.01 10.99%
Price 2.71
S1 2.71 -0.0737%
S2 2.70 -0.442%
S3 2.63 -3.02%

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates BioLineRx Ltd. (BLRX) as a Sell Candidate with a technical score of -1.72 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 07, 2026, the price has risen 0.07%. The current 3-month trend forecast projects a fall of 11.37%.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the Aug 10, 2026, the price of an BioLineRx Ltd. (BLRX) share was $2.71.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $4.56 and the 52-week low is $2.18.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the Aug 10, 2026, the market capitalization of BioLineRx Ltd. is 11.801M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE